AstraZeneca’s release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it. But just hours after its announcement, American officials issued an unusual statement expressing concern the company had included “outdated information” from its study and that it may have provided “an incomplete view of the efficacy data.”
Related posts
-
Apartment developer launches Yorktown mall project; first phase calls for 271 units
Going into the busy holiday shopping season, visitors to Yorktown Center are seeing visible progress on... -
‘Patty is not a victim’: Patricia Columbo again denied parole for 1976 Elk Grove murders
Illinois’ Prisoner Review Board denies parole for Patricia Columbo, 68, who - along with her boyfriend... -
InterFaith Aurora to hold Thanksgiving, unity celebration
InterFaith Aurora will hold a Thanksgiving celebration Sunday at New England Congregational Church in Aurora. The...